GlaxoSmithKline logo

Scientific R&D

Research & development
Combing global coverage with small, therapeutically aligned research units, our R&D organisation enjoys the advantages of size and speed. Early on in the research enterprise, our size enables us to screen upwards of a million compounds in the hunt for novel drug targets. In the later stages we're able to conduct large, late-stage clinical trials on a global scale. And working closely with the clinical groups are the regulatory-affairs and marketing staff who ensure that all our efforts directly address the needs of medical professionals and their patients.

Scientific research & development

Genetics research
Through genetic research, we hope to find reliable means for predicting patients' responses to medicines, as well as identifying genes that confer susceptibility to common diseases. Studying disease processes at a genetic level also enables us to identify new drug targets, and ultimately develop safer, more effective treatments.

Discovery research
An early step in creating new medicines is finding compounds that interfere with the mechanisms of disease, so our Discovery Research scientists generate lead compounds to serve as candidates for further development into medicines. Drawing upon their expertise in chemistry and biology they work with some of the most advanced, automated technologies available today.

Drug discovery
Our Centres of Excellence for Drug Discovery (CEDDs) are therapeutically aligned research units that enable scientists to take charge of their own research direction. Studying disease mechanisms targeted for treatment, identifying drug candidates and elucidating functional effects of the most promising compounds, they collaborate with colleagues across the company to transform them into medicines.

Preclinical development
As well as supplying chemicals for developing drug formulations used in clinical trials, the PreClinical Development researchers investigate dosage form and find ways to enhance a drug's effectiveness. In addition, this division develops processes and analytical methods for synthesis, formulation and delivery, as well as enhancements throughout the product's lifecycle.



Back to top
Research and development
Research & development
Find out more

About R&D at GSK

Image of disability symbol
Accessibility and disability